Lv0
0 积分 2026-01-24 加入
2016 FDA drug approvals
2个月前
已完结
Bibliometric analysis of literature on natural medicines against chronic kidney disease from 2001 to 2024
2个月前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
3个月前
已完结
ArenaissanceintargetingthePI3K/AKT/mTOR pathway
4个月前
已完结
Effects of Sacubitril Valsartan Combined With Vericiguat on NT-proBNP and CK-MB Levels in Patients With Chronic Heart Failure
4个月前
已完结
Insights Into Vepdegestrant (ARV-471): The First-in-Class Estrogen Receptor Proteolysis-Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
4个月前
已完结
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
5个月前
已完结
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
5个月前
已完结
Top companies and drugs by sales in 2025
5个月前
已关闭
皖公网安备34019202002308
